Equine healthcare market driven by launching of novel and efficient solutions by top manufacturers to quickly identify disorders is expected to grow at a CAGR of 6.30% during the forecast period 2023 to 2032

Market Research Future (MRFR) has published a cooked research report on the “Global Equine Healthcare Market” that contains information from 2018 to 2032. The equine healthcare market is estimated to register a CAGR of 6.30% during the forecast period of 2023 to 2032.

Equine Healthcare Market Highlights

The global equine healthcare market is accounted to register a CAGR of 6.30% during the forecast period and is estimated to reach USD 3.985 billion by 2032.

The market's expansion is attributed to a number of variables, including an increase in the incidence of equine diseases, an increase in the number of horses, an increase in the cost of caring for animals, an increase in demand for the use of horses for a variety of purposes, an increase in the development of equine healthcare products, a rise in public awareness of the value and advantages of using horses, and a surge in demand for pet insurance. However, it is anticipated that the equine population fall may restrain the market's expansion. 

MRFR recognizes the following companies as the key players in the global equine healthcare market - Zoetis; Ceva; MERCK & CO., INC.; SOUND; Hallmarq Veterinary Imaging; ESAOTE SPA; Boehringer Ingelheim International GmbH; Vetoquinol S.A.; IDEXX Laboratories, Inc.; and Dechra Pharmaceuticals PLC.

Segment Analysis

The global equine healthcare market has been segmented into product, indication, activity and distribution channel.

On the basis of product, the market is segmented into Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services and Others. The pharmaceuticals segment was attributed to holding the largest market share in 2022. One of the main factors is the rising necessity for specialist drugs and treatments catered exclusively to the distinctive requirements of horses. Horses need a variety of pharmacological medicines for a variety of health diseases, such as pain management, respiratory problems, and musculoskeletal illnesses, whether they are used for racing, breeding, or recreational purposes.

Based on indication, the global equine healthcare market has been segmented into Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus and Others. The parasite control segment was expected to hold the largest market share in 2022. This expansion can be linked to a number of things, including the realization of the significance of good parasite control in preserving the health and welfare of horses. Weight loss, colic, and skin irritations are just a few of the problems that parasites like internal worms and external pests like ticks and flies can cause in horses.

On the basis of activity, the worldwide equine healthcare market has been divided into Sports/Racing, Recreation and Others. In 2022, it was anticipated that the sports/racing category would account for the biggest market share. This is because the horse racing and sports industries are thriving in key markets like the United States, the Netherlands, France, China, and Australia. The Fédération Équestre Internationale, a body that regulates equestrian sports internationally, recognizes about 8 disciplines in both normal and para-equestrian competition.

The global equine healthcare market has been segmented into veterinary hospitals & clinics, e-commerce and others based on distribution channel. The veterinary hospitals & clinics category was predicted to hold the largest market share in 2022. The growing need for specialized and cutting-edge equine healthcare services is a major factors driving this rise. Regular check-ups, diagnostics, and specialized treatments are becoming increasingly important to horse owners and experts in the equine sector in order to ensure the health and wellbeing of their equine companions.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Equine Healthcare Market Research Report

Regional Analysis

The global equine healthcare market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe equine healthcare market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The equine healthcare market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World equine healthcare market comprises of Middle East, Africa, and Latin America.

The largest market share for equine healthcare was maintained by the North American regional sector. There are several equine-related factors in the area, including a large equine population, significant animal health spending, and an increase in equine immunization programs. Additionally, one of the major factors influencing the expansion of the market under study in North America is the availability of qualified veterinarians in the United States.

Moreover, the Europe market has been persistently growing over the forecast period. Numerous elements, including a high adoption rate of horses per family, exceptional animal healthcare expenditures, the impact of animal welfare programs, a strong infrastructure for animal research, and the presence of significant suppliers, are responsible for the two regions' sizable market shares.

Additionally, Asia Pacific is anticipated to experience the quickest growth over the forecast period. Some of the drivers driving the market include an increase in the demand for horse medicinal feeds, a growth in the prevalence of equine illnesses, and an increase in government initiatives to promote equine health.

Furthermore, the rest of the world's equine healthcare market is divided into the Middle East, Africa, and Latin America. During the projected period, the equine healthcare market will expand across the rest of the world due to the increased awareness of animal healthcare. Animal health is essential for the safety and wellbeing of both animals and humans, and this understanding is expanding as more people become aware of how vital animals are to the environment.

Key Findings of the Study

• The global equine healthcare market is expected to reach USD 3.985 billion by 2032, at a CAGR of 6.30% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market. Increasing equine illness prevalence, rising demand for horse medicinal feeds, and an increase in government initiatives to support equine health are a few of the reasons propelling the market.


• Based on product, the pharmaceuticals segment was attributed to holding the largest market in 2022, with an approximate market share of 30%.


• Zoetis; Ceva; MERCK & CO., INC.; SOUND; Hallmarq Veterinary Imaging; ESAOTE SPA; Boehringer Ingelheim International GmbH; Vetoquinol S.A.; IDEXX Laboratories, Inc.; and Dechra Pharmaceuticals PLC.